1921
Volume 93, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

An increase of sexually transmitted shigellosis is currently being reported in developed countries. In addition, travel-related shigellosis can introduce resistant strains that could be disseminated within this new scenario. Epidemiological features and antimicrobial susceptibility of shigellosis depending on where infection was acquired were investigated. From 2008 to 2013, subjects with shigellosis were studied. Patients were classified according to acquisition of as traveler's diarrhea (TD) or domestically acquired diarrhea (DAD). Ninety cases of shigellosis were identified: 76 corresponding to the TD group and 14 to the DAD group. In the DAD group, most of patients were human immunodeficiency virus (HIV)-positive men who have sex with men (MSM), being shigellosis associated to male sex ( = 0.007) and HIV infection ( < 0.0001). (47.8%) and (42.2%) were the predominant species. The highest resistance was detected for trimethoprim/sulfamethoxazole (SXT) (81.8%), followed by ampicillin (AMP) (37.8%) and ciprofloxacin (CIP) (23.3%). Resistant strains were more frequent in subjects with TD than those with DAD, although only for CIP the difference was significant ( = 0.034). Continuous monitoring of patients with shigellosis is necessary to control the spread of resistant strains and for effective therapy. Men with shigellosis who have not traveled to an endemic area should be screened for HIV infection.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.14-0804
2015-09-02
2017-09-26
Loading full text...

Full text loading...

/deliver/fulltext/14761645/93/3/491.html?itemId=/content/journals/10.4269/ajtmh.14-0804&mimeType=html&fmt=ahah

References

  1. Okhuysen PC, , 2005. Current concepts in traveller's diarrhea: epidemiology, antimicrobial susceptibility and treatment. Curr Opin Infect Dis 18: 522526.[Crossref]
  2. Zaidi MB, Estrada-García T, , 2014. Shigella: a highly virulent and elusive pathogen. Curr Trop Med Rep 1: 8187.
  3. Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, Sansonetti PJ, Adak GK, Levine MM, , 1999. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ 77: 6566.
  4. Bardhan P, Faruque AS, Naheed A, Sack DA, , 2010. Decrease in shigellosis-related deaths without Shigella spp.-specific interventions, Asia. Emerg Infect Dis 16: 17181723.[Crossref]
  5. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, Griffin PM, Tauxe RV, , 1999. Food-related illness and death in the United States. Emerg Infect Dis 5: 607625.[Crossref]
  6. Carlos III Health Institut, 2014. Weekly Epidemiological Bulletin. Available at: http://revista.isciii.es/bes/issue/archive/2014. Accessed February 18, 2015.
  7. Culqui DR, García-de-Olalla-Rizo P, Alva-Chavez KP, Lafuente S, Rius C, de Simón M, Sabater S, Caylá JA, , 2015. Analysis of the epidemiological pattern of Shigellosis in Barcelona between 1988 and 2012: is it an emerging sexually transmitted infection? Enferm Infecc Microbiol Clin 33: 379384. Available at: http://www.sciencedirect.com/science/article/pii/S0213005X14003346.[Crossref]
  8. Aragón TJ, Vugia DJ, Shallow S, Samuel MC, Reingold A, Angulo FJ, Bradford WZ, , 2007. Case-control study of shigellosis in San Francisco: the role of sexual transmission and HIV infection. Clin Infect Dis 44: 327334.[Crossref]
  9. Bader M, Pedersen AH, Williams R, Spearman J, Anderson H, , 1977. Venereal transmission of shigellosis in Seattle-King county. Sex Transm Dis 4: 8991.[Crossref]
  10. Marcus U, Zucs P, Bremer V, Hamouda O, Prager R, Tschaepe H, Futh U, Kramer M, , 2004. Shigellosis—a re-emerging sexually transmitted infection: outbreak in men having sex with men in Berlin. Int J STD AIDS 15: 533537.[Crossref]
  11. Borg ML, Modi A, Tostmann A, Gobin M, Cartwright J, Quigley C, Crook P, Boxall N, Pau J, , 2012. Ongoing outbreak of Shigella flexneri serotype 3a in men who have sex with men in England and Wales, data from 2009–2011. Eurosurveillance 17: 13.
  12. Niyogi SK, , 2005. Shigellosis. J Microbiol 43: 133143.
  13. Taneja N, , 2007. Changing epidemiology of shigellosis and emergence of ciprofloxacin-resistant Shigella in India. J Clin Microbiol 45: 678679.[Crossref]
  14. Qu M, Zhang X, Liu G, Huang Y, Jia L, Liang W, Li X, Wu X, Li J, Yan H, Kan B, Wang Q, , 2014. An eight-year study of Shigella species in Beijing, China: serodiversity, virulence genes, and antimicrobial resistance. J Infect Dev Ctries 8: 904908.[Crossref]
  15. Daskalakis DC, Blaser MJ, , 2007. Another perfect storm: Shigella, men who have sex with men, and HIV. Clin Infect Dis 44: 335337.[Crossref]
  16. Nataro JP, Bopp CA, Fields PI, Kaper JB, Strockbine NA, Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, , 2007. Escherichia, Shigella, and Salmonella . , eds. Manual of Clinical Microbiology. 9th edition. Washington, DC: American Society of Microbiology, 670687.
  17. Clinical and Laboratory Standards Institute, 2011. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement M100-S21. Wayne, PA: Clinical and Laboratory Standards Institute.
  18. Howie RL, Folster JP, Bowen A, Barzilay EJ, Whischard JM, , 2010. Reduced azithromycin susceptibility in Shigella sonnei, United States. Microb Drug Resist 16: 245248.[Crossref]
  19. Palmeiro A, Toro C, Dhabi G, Amor A, Iglesias N, Trevisi P, Blanco J, Puente S, Baquero M, , 2012. Diarrheagenic Escherichia coli pathotypes in travellers attending a tropical medicine unit in a Spanish hospital. J Med Microbiol 61: 14851487.[Crossref]
  20. Baer JT, Vugia DJ, Reingold AL, Aragon T, Angulo FJ, Bradford WZ, , 1999. HIV infection as a risk factor for shigellosis. Emerg Infect Dis 5: 820823.[Crossref]
  21. Hoffmann C, Sahly H, Jessen A, Ingiliz P, Stellbrink HJ, Neifer S, Schewe K, Dupke S, Baumgarten A, Kuschel A, Krznaric I, , 2013. High rates of quinolone-resistant strains of Shigella sonnei in HIV-infected MSM. Infection 41: 9991003.[Crossref]
  22. Vinh H, Nhu NT, Nga TV, Duy PT, Campbell JI, Hoang NV, Boni MF, My PV, Parry C, Nga TT, Van Minh P, Thuy CT, Diep TS, Phuong le T, Chinh MT, Loan HT, Tham NT, Lanh MN, Mong BL, Anh VT, Bay PV, Chau NV, Farrar J, Baker S, , 2009. A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation. BMC Infect Dis 9: 204.[Crossref]
  23. Chompook P, Samosornsuk S, von Seidlein L, Jitsanguansuk S, Sirima N, Sudjai S, Mangjit P, Kim DR, Wheeler JG, Todd J, Lee H, Ali M, Clemens J, Tapchaisri P, Chaicumpa W, , 2005. Estimating the burden of shigellosis in Thailand: 36-month population-based surveillance study. Bull World Health Organ 83: 739746.
  24. Bangtrakulnonth A, Vieira AR, Lo Fo Wong DM, Pornreongwong S, Pulsrikarn C, Sawanpanyalert P, Hendriksen RS, Aarestrup FM, , 2008. Shigella from humans in Thailand during 1993 to 2006: spatial-time trends in species and serotype distribution. Foodborne Pathog Dis 5: 773784.[Crossref]
  25. Keddy KH, Sooka A, Crowther-Gibson P, Quan V, Meiring S, Cohen C, Nana T, Sriruttan C, Seetharam S, Hoosen A, Naicker P, Elliott E, Haffejee S, Whitelaw A, Klugman KP, Group for Enteric, Respiratory, and Meningeal Disease Surveillance in South Africa (GERMS-SA); , 2012. Systemic shigellosis in South Africa. Clin Infect Dis 54: 14481454.[Crossref]
  26. Pons MJ, Gomes C, Martínez-Puchol S, Ruiz L, Mensa L, Vila J, Gascón J, Ruiz J, , 2013. Antimicrobial resistance in Shigella spp. causing traveller's diarrhea (1995–2010): a retrospective analysis. Travel Med Infect Dis 11: 315319.[Crossref]
  27. Steffen R, Hill DR, DuPont HL, , 2015. Traveler's diarrhea: a clinical review. JAMA 313: 7180.[Crossref]
  28. Vila J, Gascon J, Abdalla S, Gomez J, Marco F, Moreno A, Corachan M, Jimenez de Anta T, , 1994. Antimicrobial resistance of Shigella isolates causing traveler's diarrhea. Antimicrob Agents Chemother 38: 26682670.[Crossref]
  29. Legros D, , ed, 2005. Guidelines for the Control of Shigellosis, Including Epidemics due to Shigella Dysenteriae Type 1. Geneva, Switzerland: World Health Organization. Available at: http://www.who.int/vaccine_research/documents/Guidelines_Shigellosis.pdf. Accessed June 17, 2015.
  30. Gu B, Cao Y, Pan S, Zhuang L, Yu R, Peng Z, Qian H, Wei Y, Zhao L, Liu G, Tong M, , 2012. Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of between Europe–America and Asia–Africa from 1998 to 2009. Int J Antimicrob Agents 40: 917.[Crossref]
  31. Bhattacharya D, Bhattacharya H, Sayi DS, Bharadwaj AP, Singhania M, Sugunan AP, Roy S, , 2014. Changing patterns and widening of antibiotic resistance in spp. over a decade (2000–2011), Andaman Islands, India. Epidemiol Infect 24: 18.
  32. Gaudreau C, Barkati S, Leduc JM, Pilon PA, Favreau J, Bekal S, , 2014. Shigella spp. with reduced azithromycin susceptibility, Quebec, Canada, 2012–2013. Emerg Infect Dis 20: 854856.[Crossref]
  33. Hassing RJ, Melles DC, Goessens WH, Rijnders BJ, , 2014. Case of Shigella flexneri infection with treatment failure due to azithromycin resistance in an HIV-positive patient. Infection 42: 789790.[Crossref]
  34. Bhattacharya D, Bhattacharya H, Thamizhmani R, Sayi DS, Reesu R, Anwesh M, Kartick C, Bharadwaj AP, Singhania M, Sugunan AP, Roy S, , 2014. Shigellosis in Bay of Bengal Islands, India: clinical and seasonal patterns, surveillance of antibiotic susceptibility patterns, and molecular characterization of multidrug-resistant Shigella strains isolated during a 6-year period from 2006 to 2011. Eur J Clin Microbiol Infect Dis 33: 157170.[Crossref]
  35. Karlsson MS, Bowen A, Reporter R, Folster JP, Grass JE, Howie RL, Taylor J, Whischard JM, , 2013. Outbreak of infections caused by Shigella sonnei with reduced susceptibility to azithromycin in the United States. Antimicrob Agents Chemother 57: 15591560.[Crossref]
  36. Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM, , 2012. Azithromycin and risk of cardiovascular death. N Engl J Med 366: 18811890.[Crossref]
  37. Centers for Disease Control and Prevention, 2014. Centers of Disease Control and Prevention Health Information for Travel. York, United Kingdom: Oxford University Press. Available at: http://wwwnc.cdc.gov/travel/yellowbook/2014/chapter-2-the-pre-travel-consultation/interactions-among-travel-vaccines-and-drugs.
  38. Bhattacharya D, Sugunan AP, Bhattacharjee H, Thamizhmani R, Sayi DS, Thanasekaran K, Manimunda SP, Ghosh AR, Bharadwaj AP, Singhania M, Roy S, , 2012. Antimicrobial resistance in Shigella—rapid increase and widening of spectrum in Andaman Islands, India. Indian J Med Res 135: 365370.
  39. Njunda AL, Assob JC, Nsagha DS, Kamga HL, Awafong MP, Weledji EP, , 2012. Epidemiological, clinical features and susceptibility pattern of shigellosis in the buea health district, Cameroon. BMC Res Notes 5: 54.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.14-0804
Loading
/content/journals/10.4269/ajtmh.14-0804
Loading

Data & Media loading...

  • Received : 15 Dec 2014
  • Accepted : 13 May 2015

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error